Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Non-cash Items: 2020-2024

Historic Non-cash Items for Relay Therapeutics (RLAY) over the last 5 years, with Dec 2024 value amounting to $7.9 million.

  • Relay Therapeutics' Non-cash Items fell 45.43% to $18.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $18.9 million, marking a year-over-year decrease of 45.43%. This contributed to the annual value of $7.9 million for FY2024, which is 18.13% up from last year.
  • According to the latest figures from FY2024, Relay Therapeutics' Non-cash Items is $7.9 million, which was up 18.13% from $6.7 million recorded in FY2023.
  • In the past 5 years, Relay Therapeutics' Non-cash Items ranged from a high of $196.6 million in FY2020 and a low of $3.0 million during FY2021.
  • For the 3-year period, Relay Therapeutics' Non-cash Items averaged around $6.3 million, with its median value being $6.7 million (2023).
  • As far as peak fluctuations go, Relay Therapeutics' Non-cash Items tumbled by 98.49% in 2021, and later spiked by 50.62% in 2023.
  • Over the past 5 years, Relay Therapeutics' Non-cash Items (Yearly) stood at $196.6 million in 2020, then tumbled by 98.49% to $3.0 million in 2021, then surged by 48.60% to $4.4 million in 2022, then spiked by 50.62% to $6.7 million in 2023, then climbed by 18.13% to $7.9 million in 2024.